BioSpace News Archive

Business

Acerus Acquires Canadian Rights to Novel Pain Relief Product for Gynecological Procedures from Pharmanest

Acerus Pharmaceuticals Corporation today announced that it has entered into an exclusive agreement to commercialize Pharmanest AB (“Pharmanest”) Short Acting Lidocaine product (“SHACT”), a novel pain relief drug device combination in Canada.

May 29, 2018

·

7 min read

Second OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy Held in Shanghai, Promoting Precision Medicine of China to Go Global

On May 26, 2018, the Second OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy was held in Shanghai. Themed on “Broader Vision, Deeper Insight”.

May 29, 2018

·

6 min read

Biotech Beach

Rigel Announces Availability of TAVALISSE™ (fostamatinib disodium hexahydrate) in the U.S.

Rigel Pharmaceuticals, Inc. announced that TAVALISSE™ (fostamatinib disodium hexahydrate) is available by prescription for the treatment of thrombocytopenia in adult patients.

May 29, 2018

·

7 min read

Policy

Stallergenes Greer plc: Two New Real-World Evidence Studies Show Long-Term Benefits of Sublingual Allergy Immunotherapy

Stallergenes Greer announced positive results from two real-world evidence studies regarding the use of allergy immunotherapy (AIT) compared to the use of only symptomatic treatments to treat patients with respiratory allergies.

May 29, 2018

·

11 min read

Breakthrough hydrolysis technology transforms animal by-products and food waste into organic fertilizer and green energy.

An innovative Canadian technology targeting global markets has successfully completed commercial scale processing of livestock carcass by-products into fertilizers at the Lethbridge Biogas biorefining plant.

May 29, 2018

·

2 min read

Drug Development

Atox Bio Announces Enrollment of First Patient in Phase 2 Study of Acute Kidney Injury (AKI)

Atox Bio [http://www.atoxbio.com ], today announced that the first patient has been enrolled in the Phase 2 REAKT (Reltecimod E fficacy for Acute Kidney Injury T rial) study.

May 29, 2018

·

3 min read

Policy

Volumes Achieved as Haiti’s ‘Change Caravan’ Marks Its First Year

In the one year since Haiti’s President Jovenel Moïse launched his flagship ‘Change Caravan’ initiative, the country has experienced significant improvements across several areas.

May 29, 2018

·

3 min read

Policy

Is This Antipsychotic a Crapshoot?

A drug that causes people to gamble? This has to be a scapegoat for bad behavior or another crazy lawsuit like McDonald’s and the too hot coffee.

May 29, 2018

·

2 min read

Isolation and Recombinant Expression of Key Enzyme for Opioid Production

Intrexon Corporation announced the isolation and recombinant expression of a novel gene from the opium poppy (Papaver somniferum) encoding the enzyme, thebaine synthase.

May 29, 2018

·

5 min read

Pharm Country

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

Aevi Genomic Medicine, Inc. announced that Michael F. Cola, President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference.

May 29, 2018

·

2 min read